Mycophenolic Acid FDA Link Generic

Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION.

Also Known As:

Cellcept; Mycophenolate Mofetil; Mycophenolate Mofetil Hydrochloride; Mycophenolate Sodium; Mycophenolic Acid Morpholinoethyl Ester; Myfortic; RS 61443; RS-61443; Sodium Mycophenolate; Mofetil Hydrochloride, Mycophenolate; Mofetil, Mycophenolate; Mycophenolate, Sodium; RS61443; -Hexenoic acid, 6- (1,3- dihydro- 4- hydroxy- 6- methoxy- 7- methyl- 3- oxo- 5- isobenzofuranyl)- 4- methyl- , (E)-

Pharmalogical Action Categories:

Antibiotics, Antineoplastic
Enzyme Inhibitors

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Acyclic Acids
    - Caproates: 7
      - Mycophenolic Acid: 3948
Lipids: 114793
- Fatty Acids: 27405
  - Mycophenolic Acid: 3948

Pablo Díaz de Rada Selected Research

Pablo Díaz de Rada Research Topics

Disease

Drug/Important Bio-Agent (IBA)